Table 1 Baseline characteristics of the enroled infants
Characteristic | GLSE (n = 52) | Beractant (n = 46) | p-value |
|---|---|---|---|
Maternal | |||
Antibiotics in 7 days before delivery | 18 (34.6) | 18 (39.1) | 0.64 |
Gestational diabetes | 6 (11.5) | 3 (6.5) | 0.39 |
Antenatal steroids | |||
None/unknown | 8 (15.4) | 8 (17.4) | |
Incomplete | 17 (32.7) | 18 (39.1) | 0.70 |
Complete | 27 (51.9) | 20 (43.5) | |
Clinical chorioamnionitis | (n = 47) | (n = 43) | 0.35 |
3 (6.4) | 1 (2.3) | ||
Rupture of membranes for ≥18 h | 16 (30.8) | 8 (17.4) | 0.12 |
Cesarean delivery | 23 (44.2) | 18 (39.1) | 0.61 |
Antepartum hemorrhage | 14 (26.9) | 7 (15.2) | 0.16 |
Neonatal | |||
Gestation in weeks | 29.2 ± 1.9 | 29.2 ± 1.8 | 0.84 |
Birth weight, g | 1192 ± 312 | 1156 ± 298 | 0.56 |
Small for gestational age | 6 (11.5) | 5 (10.9) | 0.63 |
Male gender | 25 (48.1) | 36 (78.3) | 0.002 |
Multiple births | 13 (25.0) | 12 (26.1) | 0.90 |
Positive pressure ventilation (PPV) at birth | 32 (61.5) | 22 (47.8) | 0.17 |
Delayed cord clamping | 6 (11.5) | 6 (13.1) | 0.82 |
Delivery room CPAP | 22 (42.3) | 24 (52.2) | 0.33 |
Median age at eligibility, h | 1.0 (0.2, 2) | 1.5 (1, 3.8) | 0.82 |
Median age at surfactant administration, h | 2.4 (1.7, 4.5) | 2.4 (1.8, 4.7) | 0.61 |
InSurEa | 29 (55.8) | 32 (69.6) | 0.16 |
